Product Information
CARTIA XT 180 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.1877 per EA under NDC 62037059890. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jul 9, 1998. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
180 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
62037059890
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074752FDA Approved
7/9/1998
TE Code
AB3
On Market Since
7/9/1998
Pharmacological Classes
Price Statistics
The NADAC for CARTIA XT 180 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 48.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1877 per EA |
|---|---|
| All-time high | $0.4373 (May 13, 2015) |
| All-time low | $0.1492 (Jul 17, 2024) |
| 52-week high | $0.1884 |
| 52-week low | $0.1790 |
| Median price | $0.2703 |
| Average price | $0.2689 |
| Largest weekly change | +44.1% (Jun 19, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARTIA XT 180 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CARTIA XT 180 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.1877 per EA (NDC 62037059890), effective Aug 19, 2026.
How has the price of CARTIA XT 180 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CARTIA XT 180 MG CAPSULE has declined 48.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARTIA XT 180 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CARTIA XT 180 MG CAPSULE has ranged from a low of $0.1492 (Jul 17, 2024) to a high of $0.4373 (May 13, 2015), with a median of $0.2703 per EA.
Are there cheaper alternatives to CARTIA XT 180 MG CAPSULE?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DILTIAZEM 24HR ER 180 MG CAP, is $0.1160 per EA — about 38% below CARTIA XT 180 MG CAPSULE.
Who manufactures CARTIA XT 180 MG CAPSULE?
CARTIA XT 180 MG CAPSULE (NDC 62037059890) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.